Current cell therapies for systemic lupus erythematosus.

Area of Science:

• Immunology
• Rheumatology
• Cell Therapy

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune disease causing multi-organ damage.
• Current treatments like hydroxychloroquine and glucocorticoids manage symptoms but do not cure SLE.
• There is a critical need for innovative therapies to treat SLE effectively.

Purpose of the Study:

• To review recent clinical trials on cell therapies for SLE treatment.
• To discuss the potential of emerging cell-based therapies for SLE.
• To highlight factors influencing cell therapy selection for individual SLE patients.

Main Methods:

• Review of recent clinical trials involving cell therapies for SLE.
• Analysis of various cell therapy approaches including hematopoietic stem cell transplantation, mesenchymal stem cells, regulatory T cells, natural killer cells, and CAR T cells.
• Discussion of advantages, disadvantages, and future research needs for these therapies.

Main Results:

• Several advanced cell therapies have been evaluated in human clinical trials for SLE.
• Each cell therapy approach presents unique benefits and drawbacks.
• Further investigation is required to establish definitive safety and efficacy.

Conclusions:

• Cell therapies represent a promising frontier in SLE management.
• Understanding the nuances of different cell therapies is crucial for patient-specific treatment selection.
• Continued research and clinical trials are essential to optimize cell-based treatments for SLE.